Wire · opportunities
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 26 August 2026 · Fusion42 review
Abbott received FDA authorization for Libre Duo 10 Day, the first dual glucose-ketone sensing wearable that provides real-time glucose monitoring and alerts for rising ketones to prevent diabetic ketoacidosis (DKA). The device integrates with the latest Libre app and is compatible with leading automated insulin delivery systems, aiming to reduce serious DKA risks.
This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 25 Aug 2026 and 26 Aug 2026.
◆ ◆ The Wire takeaway
Diabetes device makers just gained permission to combine glucose and ketone monitoring into a single wearable. If you build diabetes hardware or software, start integrating ketone sensing or partner with Abbott to stay competitive.
◆ Coverage
4 sources · first reported 25 Aug 2026 · latest 26 Aug 2026
◆ Related on Wire
◆ Topics